Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma, Ewing × romiplostim × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1

Interventions

Temozolomide 7 cabozantinib 3 Vincristine 3 Irinotecan 3 Cyclophosphamide 3 liposomal doxorubicin 2 irinotecan sucrosofate 2 fludarabine 2 Zoledronic Acid 2 Specimen Handling 2 Radiotherapy 2 PM 01183 2 Drug Therapy 2 trilaciclib 1 talazoparib 1 silmitasertib 1 romiplostim 1 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 naxitamab 1 fluzoparib 1 fludarabine phosphate 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Triptorelin Pamoate 1 Topotecan 1 Tacrolimus 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07048249 2026-03-18

Single Arm Romiplostim to Prevent CIT

Children's Hospital Medical Center, Cincinnati

Phase EARLY_PHASE1 Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡